These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5876464)

  • 41. [A modified method for rapid identification of tick-borne and Japanese encephalitis viruses in the hemagglutination-inhibition test].
    Tsirkin IuM
    Vopr Virusol; 1965; 10(6):669-74. PubMed ID: 4290512
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of the effectivity of a new preparation-the tissue culture vaccine against tick-borne encephalitis.
    LEVKOVICH JN; ZASUCHINA GD
    J Hyg Epidemiol Microbiol Immunol; 1960; 4():296-8. PubMed ID: 13761570
    [No Abstract]   [Full Text] [Related]  

  • 43. Study of the possibility of preparing a vaccine against tick-borne encephalitis using tissue culture methods. 3. Experimental principles for safety tests of virus inactivation in formolized liquids.
    BENDA R; DANES L
    Acta Virol; 1960 Sep; 4():296-307. PubMed ID: 13849000
    [No Abstract]   [Full Text] [Related]  

  • 44. STUDY OF HAEMAGGLUTINATING PROPERTIES OF VIRUSES OF THE TICK-BORNE ENCEPHALITIS COMPLEX PROPAGATED IN VARIOUS CELL CULTURES.
    KARPOVICH LG; IZOTOV VK
    Acta Virol; 1964 Jul; 8():376-7. PubMed ID: 14204752
    [No Abstract]   [Full Text] [Related]  

  • 45. [Research on the tick-borne encephalitis; I. Biology of the tick-borne encephalitis viral strains isolated in Poland].
    PRZESMYCKI F; TAYTSCH Z; SEMKOW R; WALENTYNOWICZ-STANCZYK
    Przegl Epidemiol; 1954; 8(3):205-14. PubMed ID: 13224769
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cultivation of viruses of the tick-borne encephalitis group in SCH cells].
    KARPOVICH LG; ZASUKHINA GD
    Vopr Virusol; 1959; 4(2):213-8. PubMed ID: 13659974
    [No Abstract]   [Full Text] [Related]  

  • 47. [Changes in the sensitivity of the body to heterologous viral infections following immunization with different virus vaccines. I. The ability of live polio vaccine and tick-borne encephalitis vaccine to evoke resistance to heterologous viral infections].
    Gorshunova LP; Nabokova AV
    Br J Soc Clin Psychol; 1970 Dec; 9(4):83-6. PubMed ID: 5494794
    [No Abstract]   [Full Text] [Related]  

  • 48. [MATERIALS FOR STUDY OF IMMUNOLOGICAL SHIFTS IN SUBJECTS VACCINATED AND REVACCINATED WITH TISSUE ENCEPHALITIS VACCINE].
    UNANOV SS; SHUTOV AV
    Vopr Virusol; 1964; 42():604-8. PubMed ID: 14256626
    [No Abstract]   [Full Text] [Related]  

  • 49. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

  • 51. [POSTVACCINAL AND POSTINFECTION IMMUNITY IN TICK ENCEPHALITIS].
    SEMENOV BF; KARASEVA PS; KURANOVA LK; SALANOVA TA
    Vopr Virusol; 1964; 42():597-601. PubMed ID: 14256624
    [No Abstract]   [Full Text] [Related]  

  • 52. [Growth of strains of viruses of tick-borne encephalitis in chick embryo & HeLa cells tissue cultures].
    ANDONOV PS; SHUBLADZE AK
    Vopr Virusol; 1959; 4(1):94-100. PubMed ID: 13659950
    [No Abstract]   [Full Text] [Related]  

  • 53. [Assessment of the immunologic effectiveness of a concentrated purified vaccine against tick-borne encephalitis in experiments on animals].
    Korovina GI; Titova TS; Churnosov EV
    Tr Inst Im Pastera; 1989; 65():150-5. PubMed ID: 2629183
    [No Abstract]   [Full Text] [Related]  

  • 54. Experimental pathogenicity of tick-borne encephalitis virus for dogs.
    Gresíková M; Weidnerová K; Nosek J; Rajcáni J
    Acta Virol; 1972 Jul; 16(4):336-40. PubMed ID: 4403175
    [No Abstract]   [Full Text] [Related]  

  • 55. [Vaccination against tick-borne encephalitis using the Soviet liquid inactivated vaccine].
    Plesník V; Januska J; Matuska J
    Cesk Epidemiol Mikrobiol Imunol; 1984 Nov; 33(6):338-45. PubMed ID: 6239701
    [No Abstract]   [Full Text] [Related]  

  • 56. [Isohemolysis with the virus of tick-borne encephalitis].
    JETTMAR HM
    Z Hyg Infektionskr; 1957; 143(4):355-63. PubMed ID: 13434262
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Persistence of antibodies against tick-borne encephalitis (TBE) virus in man].
    Hubinger MG; Hofmann H; Krausler J
    Zentralbl Bakteriol Orig; 1970; 213(2):145-51. PubMed ID: 5469992
    [No Abstract]   [Full Text] [Related]  

  • 60. Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies.
    Bender A; Jäger G; Scheuerer W; Feddersen B; Kaiser R; Pfister HW
    J Neurol; 2004 Mar; 251(3):353-4. PubMed ID: 15015020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.